跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
RIVASTIGMINA STADAFARMA 4,6 MG/24 H PARCHES TRANSDERMICOS EFG - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
RIVASTIGMINA STADAFARMA 4,6 MG/24 H PARCHES TRANSDERMICOS EFG
Approved
STANDARD
RIVASTIGMINA STADAFARMA 4,6 MG/24 H PARCHES TRANSDERMICOS EFG
Laboratorio Stada S.L.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Jul 11, 2021
Approval ID
252448f0e4692fdf
Company
Laboratorio Stada S.L.
Type
Standard
Approval Details
Approval Id
252448f0e4692fdf
Drug Cima Aemps Name
RIVASTIGMINA STADAFARMA 4,6 MG/24 H PARCHES TRANSDERMICOS EFG
Register Number
86084
Holder Company Name
Laboratorio Stada S.L.
Marketing Company Name
Laboratorio Stada S.L.
Authorization Date
2021-07-11
Dosage Form
PARCHE TRANSDÉRMICO
Dose
4,6 mg/24 h
Route Of Administration
VÍA TRANSDÉRMICA
Prescription Type
Diagnóstico Hospitalario
Commercialized
Yes
Company Name
Laboratorio Stada S.L.
Active Ingredients
RIVASTIGMINA
6,9 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Jul 11, 2021
Approval ID
252448f0e4692fdf
Type
Standard
Back to CIMA-AEMPS Approvals